Literature DB >> 30885911

Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation.

Jeremiah D Momper1, Jin Yang2, Mary Gockenbach2, Florin Vaida3, Sanjay K Nigam4.   

Abstract

BACKGROUND AND OBJECTIVES: The neonatal and juvenile human kidney can be exposed to a variety of potentially toxic drugs (e.g., nonsteroidal anti-inflammatory drugs, antibiotics, antivirals, diuretics), many of which are substrates of the kidney organic anion transporters, OAT1 (SLC22A6, originally NKT) and OAT3 (SLC22A8). Despite the immense concern about the consequences of drug toxicity in this vulnerable population, the developmental regulation of OATs in the immature postnatal kidney is poorly understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Recognizing that today it is difficult to obtain rich data on neonatal kidney handling of OAT probes due to technical, logistic, and ethical considerations, multiple older physiologic studies that used the prototypical organic anion substrate para-aminohippurate (PAH) were reanalyzed in order to provide a quantitative description of OAT-mediated tubular secretion across the pediatric age continuum. Parametric and semiparametric models were evaluated for kidney function outcome variables of interest (maximum tubular secretory capacity of PAH [TmPAH], effective renal plasma flow [ERPF], and GFR).
RESULTS: Data from 119 neonates, infants, and children ranging in age from 1 day to 11.8 years were used to fit TmPAH, ERPF, and GFR as functions of postnatal age. TmPAH is low in the immediate postnatal period and increases markedly after birth, reaching 50% of the adult value (80 mg/min) at 8.3 years of age. During the first 2 years of life, TmPAH is lower than that of GFR when viewed as the fraction of the adult value.
CONCLUSIONS: During postnatal human kidney development, proximal tubule secretory function-as measured using PAH, a surrogate for OAT-mediated secretion of organic anion drugs, metabolites, and toxins-is low initially but increases rapidly. Despite developmental differences between species, this overall pattern is roughly consistent with animal studies. The human data raise the possibility that the acquisition of tubular secretory function may not closely parallel glomerular filtration.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Adolescent; Anions; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cephapirin; Drug-Related Side Effects and Adverse Reactions; Hippurates; Infant, Newborn; Kidney Tubules, Proximal; Organic Anion Transporters; Renal Plasma Flow, Effective; Vulnerable Populations; clinical nephrology; diuretics; drug transporter; glomerular filtration rate; kidney; kidney development; pediatric nephrology; tubular secretion

Mesh:

Substances:

Year:  2019        PMID: 30885911      PMCID: PMC6450358          DOI: 10.2215/CJN.10350818

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

1.  Inulin, diodone, creatinine and urea clearances in newborn infants.

Authors:  R F Dean; R A McCance
Journal:  J Physiol       Date:  1947-10-15       Impact factor: 5.182

Review 2.  Organic anion transporters and their implications in pharmacotherapy.

Authors:  Arian Emami Riedmaier; Anne T Nies; Elke Schaeffeler; Matthias Schwab
Journal:  Pharmacol Rev       Date:  2012-03-28       Impact factor: 25.468

3.  Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].

Authors:  Gang Xu; Vibha Bhatnagar; Gen Wen; Bruce A Hamilton; Satish A Eraly; Sanjay K Nigam
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

Review 4.  Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.

Authors:  K L R Brouwer; L M Aleksunes; B Brandys; G P Giacoia; G Knipp; V Lukacova; B Meibohm; S K Nigam; M Rieder; S N de Wildt
Journal:  Clin Pharmacol Ther       Date:  2015-09       Impact factor: 6.875

Review 5.  Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance.

Authors:  R D Toto
Journal:  Curr Opin Nephrol Hypertens       Date:  1995-11       Impact factor: 2.894

6.  An improved method to determine renal function using inulin and p-aminohippurate (PAH) steady-state kinetic modeling.

Authors:  L Schumann; P W Wüstenberg
Journal:  Clin Nephrol       Date:  1990-01       Impact factor: 0.975

7.  Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.

Authors:  Gleb Martovetsky; James B Tee; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2013-09-13       Impact factor: 4.436

8.  Kidney versus Liver Specification of SLC and ABC Drug Transporters, Tight Junction Molecules, and Biomarkers.

Authors:  Gleb Martovetsky; Kevin T Bush; Sanjay K Nigam
Journal:  Drug Metab Dispos       Date:  2016-04-04       Impact factor: 3.922

Review 9.  Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.

Authors:  Jeremiah D Momper; Sanjay K Nigam
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-06-04       Impact factor: 4.481

10.  Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.

Authors:  W Zhou; T N Johnson; H Xu; Sya Cheung; K H Bui; J Li; N Al-Huniti; D Zhou
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-08-27
View more
  5 in total

1.  Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling.

Authors:  Samuel Dubinsky; Paul Malik; Dagmar M Hajducek; Andrea Edginton
Journal:  Clin Pharmacokinet       Date:  2022-05-05       Impact factor: 5.577

Review 2.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

Review 3.  Pharmacokinetics in children with chronic kidney disease.

Authors:  Anne M Schijvens; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2019-08-02       Impact factor: 3.714

4.  Drosophila SLC22 Orthologs Related to OATs, OCTs, and OCTNs Regulate Development and Responsiveness to Oxidative Stress.

Authors:  Darcy C Engelhart; Priti Azad; Suwayda Ali; Jeffry C Granados; Gabriel G Haddad; Sanjay K Nigam
Journal:  Int J Mol Sci       Date:  2020-03-15       Impact factor: 5.923

5.  Pharmacokinetics of Hydrochlorothiazide in Children: A Potential Surrogate for Renal Secretion Maturation.

Authors:  Sarah Jane Commander; Huali Wu; Felix Boakye-Agyeman; Chiara Melloni; Chi Dang Hornik; Kanecia Zimmerman; Amira Al-Uzri; Susan R Mendley; Barrie Harper; Michael Cohen-Wolkowiez; Christoph P Hornik
Journal:  J Clin Pharmacol       Date:  2020-10-07       Impact factor: 2.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.